Sanofi unveils new corporate brand and logo - PMLiVE
WEBFeb 4, 2022 · Sanofi has unveiled its new corporate brand image, which reflects the organisation’s ongoing transformation and modernisation. Sanofi has been involved in patient-centric scientific discovery for 50 years, developing treatments for a variety of rare diseases, establishing set standards of care in both cardiovascular disease and diabetes and leading breakthrough treatments for patients living ...
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBAug 16, 2024 | Webinars. With the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates thorough preparation and strategic planning during the design phase. Addressing these challenges early is crucial ...
FDA approves BMS’s Opdualag for metastatic or unresectable
WEBMar 23, 2022 · Bristol Myers Squibb (BMS) has announced that Opdualag (nivolumab and relatlimab-rmbw) has received approval from the US Food and Drug Administration (FDA) for the treatment of adult and paediatric patients aged 12 years or older with metastatic melanoma or melanoma which cannot be treated with …
Communique - PMLiVE
WEBCommuniqué – Volume 53. New insights in health comms innovation. Communiqué Awards 2022 – winners’ case studies. INSIGHTS – Demonstrating impact • Driving behaviour change.
Celebrating the Communiqué Awards 2021 - PMLiVE
WEBSep 3, 2021 · The hard work and dedication of healthcare comms agencies, charities and healthcare communicators was celebrated at the annual Communiqué Awards on 1 September, held in person for the first time since the beginning of the COVID-19 pandemic.. The awards ceremony, run each year by PME’s parent company Datateam, returned to the London Grosvenor House Hotel as professionals gathered face-to ...
Novartis and GSK complete oncology and vaccines swap
WEBMar 2, 2015 · Under the terms of the deal GSK is paying $5.25bn in case for Novartis’ vaccines business while Novartis is stumping up $16bn for GSK’s oncology business. The two companies are also pooling their resources in consumer health, creating a joint venture that will be 63.5% owned by GSK. Details of the asset swap were first revealed last April.
imc Group announces its rebrand as SCIRIS - PMLiVE
WEBDec 5, 2022 · International healthcare communications agency integrated medhealth communication (imc) Group has announced its rebrand as SCIRIS, further building upon its growth strategy. Under SCIRIS, the company aims to unify its teams in delivering competitive consultancy services bolstered by a background of expertise in medical communications.
KKR acquires clinical trials firm PRA International - PMLiVE
WEBJun 28, 2013 · KKR acquires clinical trials firm PRA International. US clinical research organisation (CRO) PRA International has been acquired for an undisclosed sum by global investment firm KKR. “PRA is a well positioned global CRO platform led by a talented management team with a long track record of success,” said the head of KKR’s healthcare ...
FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis
WEBDec 24, 2019 · The FDA has approved the first two generics of Pfizer and Bristol-Myers Squibb’s blockbuster anticoagulant drug Eliquis, from Micro Labs and Mylan. FDA approval doesn’t necessarily mean that the generics will be made available anytime soon, as Pfizer and BMS are claiming patent protection for several more years, but …
Decentralised clinical trials: mapping patient pathways with a focus …
WEBMar 11, 2022 · Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity. It is critical to understand the needs and key drivers of a decentralised clinical trial – considering the target patient population when designing and deploying the trial. This enables the development of effective, highly targeted recruitment and ...